Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 December, 2018 19:23 IST
Sensex ends 249 points lower; Nifty settles at 10,784
Source: IRIS | 05 Dec, 2018, 03.54PM
Comments  |  Post Comment

Indian equities ended lower on Wednesday. The Reserve Bank of India (RBI) in its fifth bi-monthly monetary policy statement for 2018-19 decided to keep key interest rates unchanged.

The RBI said, ''On the basis of an assessment of the current and evolving macroeconomic situation at its meeting today, the Monetary Policy Committee (MPC) decided to keep the policy repo rate under the liquidity adjustment facility (LAF) unchanged at 6.5 per cent.''

At the close, the benchmark 30-share index, BSE Sensex lost 249.90 or 0.69% at 35,884.41 with 25 components posting drop. Meanwhile, the broad based NSE Nifty went down by 84.55 or 0.74% at 10,784.95 with 46 components registering drop.

Major losers in the 30-share index were Sun Pharmaceutical Industries (6.59%), Tata Steel (4.27%), Tata Motors (3.70%), Cipla (3.35%), Mahindra & Mahindra (3.33%), and Coal India (2.85%).

On the other hand, Hindustan Unilever (2.07%), Housing Development Finance Corporation (1.99%), H D F C Bank (0.59%), Wipro (0.40%), Reliance Industries (0.29%), and Adani Ports and Special Economic Zone (0.12%) were the biggest gainers in the Sensex.

Market breadth was negative with 739 advances against 1,570 declines.

Sun Pharmaceutical Industries topped the value chart on the BSE with a turnover of Rs. 1,363.74 million. It was followed by Yes Bank (Rs. 764.15 million), Tata Steel (Rs. 421.93 million) and Dewan Housing Finance Corporation (Rs. 345.94 million).

The volume chart was led by Reliance Communications with trades of over 18.58 million shares. It was followed by Dish TV India (5.75 million), Yes Bank (4.40 million) and Ashok Leyland (3.31 million).

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Related Articles
Commercial Engg & Body Builders Co bags order worth Rs 1.52 bn - 19-Dec-2018 10:51
Glenmark Pharma forays into dermatology segment in U.S - 19-Dec-2018 10:33
M&M to hike stake in associate company Sampo Rosenlew - 18-Dec-2018 10:37
Glenmark Pharma gets nod for Fluocinolone Acetonide oil - 18-Dec-2018 10:08
BGR Energy Systems bags order worth Rs 494 mn from Tamilnadu Transmission Corp - 18-Dec-2018 10:04
Lupin receives approval from USFDA for Clobazam tablets - 18-Dec-2018 10:01
Ahluwalia Contracts (India) secures new order worth RS 4.25 bn - 17-Dec-2018 15:31
Lupin receives tentative USFDA approval for Tadalafil tablets - 17-Dec-2018 14:49
Gayatri Projects bags new order worth Rs 4.93 bn - 17-Dec-2018 09:43
Zydus Cadila receives USFDA approvals for two drugs - 17-Dec-2018 09:39
Biocon's API manufacturing facility completes USFDA inspection - 17-Dec-2018 09:36
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer